The US government has announced the ten drugs selected for the first round of pricing negotiations under President Biden’s Inflation Reduction Act (IRA). The IRA allows Medicare, the government health ...

Global healthcare communications and insights research agency Porterhouse Medical Group is joining imc group with the support of Waterland Private Equity. Porterhouse offers strategic medical ...

A group of scientists from the University of Surrey have shared findings from a seven-year research study, revealing that a new approach could be on the horizon for treating one of the most prevalent ...

A wide range of top-performing healthcare comms agencies, charities and healthcare communicators claimed the honours at last night’s annual Communiqué Awards. The awards, run every year by PMLive’s ...

BioNTech has announced it will acquire UK AI start-up InstaDeep in a deal worth up to £562m, following the company’s initial equity investment as part of InstaDeep’s Series B financing round in ...

Pfizer and Clear Creek Bio have announced a collaboration aiming to advance the discovery and development of novel papain-like protease (PLpro) inhibitors and potentially introduce a new class of oral ...

Merck & Co is closing on a new indication for its checkpoint inhibitor Keytruda in early bladder cancer in the US, following a positive vote by an FDA expert panel. The Oncologic Drugs Advisory ...

This year, due to the COVID-19 pandemic and social distancing requirements, the PMEA Awards event will be streamed live at pmlive.com/pmea2020. After receiving a high ...

The European Union is demanding that AstraZeneca (AZ) delivers 120 million doses of its COVID-19 vaccine by the end of June, threatening financial sanctions if the company fails to meet this target.

Merck KGaA and Pfizer have staked a claim to the first-line renal cell carcinoma market, with data on a new combination that analyst say could challenge to become a new standard for the disease. The ...

Envision Pharma Group is expanding its Envision the Patient team with the appointment of Amanda Boughey, who joins from Cancer Research UK. Amanda joins the award winning team as its new Global ...

A new COVID-19 subvariant, XBB.1.5, is causing concern in the US, where it has been spreading rapidly since December. Data from the US Centers for Disease Control and Prevention (CDC) has estimated ...